Search
for

    Sort by

    Research 301–330 of 1000+

    1. Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review Archives of Dermatological Research · 2025 · 3 citations
    2. Botulinum Toxin Off-Label Use in Dermatology: A Review Skin appendage disorders · 2017 · 53 citations
    3. Evidence for the off-label use of tofacitinib in alopecia areata Scientific Electronic library online (Sciences Carlos III Health Institute) · 2025
    4. Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art Molecules · 2022 · 5 citations
    5. Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis Life · 2024 · 10 citations
    6. Off-label uses of retinoids in dermatology Our Dermatology Online · 2012 · 6 citations
    7. Beyond Minoxidil: Evidence-Based Off-Label Therapies for Male Androgenetic Alopecia Open Science Framework · 2026
    8. Facial hair enhancement with minoxidil—an off-label use SAGE Open Medical Case Reports · 2024
    9. Review of Promising Off-Label Use of Deucravacitinib International Journal of Molecular Sciences · 2025
    10. Cicatricial alopecia Journal der Deutschen Dermatologischen Gesellschaft · 2018 · 23 citations
    11. Real-world pharmacovigilance insights into drug-induced risk of alopecia Frontiers in Pharmacology · 2025
    12. Bicalutamide: A review Journal of Cutaneous and Aesthetic Surgery · 2024
    13. JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology Medicina · 2026
    14. Use of H-1 Antihistamine in Dermatology: More than Itch and Urticaria Control: A Systematic Review Dermatology and Therapy · 2021 · 7 citations
    15. Efficacy and Safety of Spironolactone in Acne Management Cutis · 2025
    16. New treatment modalities of alopecia areata International Journal of Dermatology Venereology and Leprosy Sciences · 2025
    17. Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis Journal of Advanced Research · 2024 · 8 citations
    18. Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases Oncotarget · 2016 · 24 citations
    19. Evolving CRBN ligands enhance the drug-like properties of protein degraders Journal of Enzyme Inhibition and Medicinal Chemistry · 2026
    20. Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis Journal of the American Academy of Dermatology · 2018 · 49 citations
    21. Protein degradation: expanding the toolbox to restrain cancer drug resistance Journal of Hematology & Oncology · 2023 · 7 citations
    22. Clinical Trials and Hair Loss Elsevier eBooks · 2018 · 1 citations
    23. Female Pattern Hair Loss international journal of endocrinology and metabolism · 2013 · 57 citations
    24. Gender differences in adverse effects and dosing practices of low-dose oral minoxidil for androgenetic alopecia: a retrospective analysis of 310 patients Skin Appendage Disorders · 2024
    25. The state‐of‐the‐art in the management of androgenetic alopecia: A review of new therapies and treatment algorithms JEADV Clinical Practice · 2022 · 1 citations
    26. Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study Journal of The American Academy of Dermatology · 2023
    27. Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review Toxins · 2021 · 58 citations
    28. Side Effects Related to 5 α-Reductase Inhibitor Treatment of Hair Loss in Women: A Review. PubMed · 2016 · 6 citations
    29. Utilities of Botulinum Toxins in Dermatology and Cosmetology Clinical Cosmetic and Investigational Dermatology · 2021 · 23 citations
    30. Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy JAAD Case Reports · 2023 · 7 citations